Site Management/Investigator Payments White Papers & Case Studies
-
Selecting A Central Lab Network For Radiopharmaceutical Readiness
9/29/2026
A wave of late-stage radiopharmaceutical trials is straining lab infrastructure concentrated in a handful of academic centers, limiting site diversity, expertise, and trial capacity nationwide.
-
Turning Urgency Into Progress And Advancing New Hope In AML
9/22/2026
A disrupted AML trial stabilized mid-study, cutting genetic testing turnaround to 1–2 days and keeping enrollment on track for patients who can't wait.
-
Digital Twins: From Protocol Design to Predictive Study Execution
9/14/2026
A growing generation of AI-enabled digital twin approaches offers a new path. Instead of treating the protocol as a static document, organizations can model it as a dynamic system.
-
Executing A Complex Global Breast Cancer Trial In A Rapidly Evolving Treatment Landscape
9/14/2026
See how rapid site activation, strong oncology site relationships, and adaptive protocol management kept a complex global cancer trial on track amid evolving standards of care.
-
Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development
9/8/2026
Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.
-
Early QT/TQT Studies
8/24/2026
Cut cardiac safety timelines and potentially waive TQT studies. Dr. Vince Clinical Research's Clario-certified Phase I unit combines 48-channel telemetry with EPQT expertise to meet ICH E14 requirements faster.
-
Renal And Hepatic Impairment Studies
8/24/2026
Explore how experienced teams, strategic site partnerships, and comprehensive research capabilities can help streamline complex organ impairment studies and support high-quality outcomes.
-
Accelerating Recruitment In A Challenging Phase III Rare Disease Trial
8/18/2026
Recruiting for rare acute diseases is challenging. Discover how this organization used rapid site activation and investigator engagement to speed enrollment in a Phase III Anti-GBM trial.
-
Advancing Lung Cancer Trials With Precision
8/17/2026
Learn how specialized clinical expertise and global site networks accelerate complex trials. Streamline recruitment and advance novel therapies with proven operational solutions.
-
How a Biopharmaceutical Company Improved Site Satisfaction
8/12/2026
Eliminate site payment delays and reduce clinical trial admin burden. Learn how one sponsor cut payment timelines from 120+ days to under 30 days while boosting site satisfaction.